Market Place
Sourcing Support
Immunocore Announces KIMMTRAK? Reimbursement For Uveal Melanoma
02 Dec 2024 //
GLOBENEWSWIRE
Co-Founder Of Shire Pharma Appointed COO Of Klotho Neurosciences
15 Oct 2024 //
GLOBENEWSWIRE
UCL Partners With Brinton Healthcare To Explore Nanoparticles
11 Oct 2024 //
EXPRESSPHARMA
Flemming mulls IPO for Galderma; Reistone shows results from eczema study
11 Oct 2021 //
ENDPTS
FDA offers support for Takeda`s potential cytomegalovirus drug
07 Oct 2021 //
ENDPTS
Delix snags $70M series A for psychedelic analog trials in 2022
27 Sep 2021 //
FIERCEBIOTECH
Takeda bags Japanese rights to maralixibat; Boehringer acquires Abexxa Biologics
21 Sep 2021 //
ENDPTS
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit
15 Sep 2021 //
FIERCEPHARMA
Takeda offloads heart, metabolic drugs in China for $322M
24 Dec 2020 //
FIERCE PHARMA
Is Takeda’s post-Shire sell-off approaching its final days?
20 Aug 2020 //
ENDPOINTSNEWS
Takeda poised to cut sales jobs in Japan as restructuring continues
29 Jul 2020 //
PHARMAFILE
Takeda’s post-merger deals continue as OTC subsidiary is prepared for sale
08 Jul 2020 //
ENDPTS
Novartis pulls Takeda-bought dry eye med Xiidra in Europe
27 Jun 2020 //
FIERCE PHARMA
Companies in the Ophthalmology Drugs Market are Investing in Global Expansion
02 Jun 2020 //
PRNEWSWIRE
Once a gem, now just a rock, Takeda punts PhIII IBD drug as rivals muscle ahead
29 May 2020 //
ENDPTS
7 Japan Major Drug Makers See Limited Impact from COVID-19: FY2019 Earnings
18 May 2020 //
PHARMAJAPAN
Servier bags an antibody specialist in its latest oncology M&A deal
04 Apr 2020 //
ENDPTS
Takeda antes up $44M for rare disease pact, turning to Oxford spinout`s
26 Mar 2020 //
COM
Pharvaris nabs Shire exec as new CMO
08 Feb 2020 //
FIERCE BIOTECH
Takeda again lifts annual forecast as Shire integration yields faster savings
04 Feb 2020 //
FIRSTWORDPHARMA
Ex-Shire/Takeda clinical trials chief lands at Moderna
31 Jan 2020 //
FIERCE BIOTECH
Shire surprises Takeda with €398M tax bill on AbbVie breakup fee
14 Jan 2020 //
FIERCE PHARMA
Patient Input and Clinical Experts: Vonvendi
03 Jan 2020 //
CADTH
What does $62B buy you these days? A lot, says Takeda execs as the pharma player
15 Nov 2019 //
ENDPTS
Pharvaris debuts with $66M to push oral HAE drug through the clinic
10 Sep 2019 //
FIERCE BIOTECH
Takeda recalls eye drug Natpara, warns patients not to abruptly stop treatment
07 Sep 2019 //
FIERCEPHARMA
Takeda-Shire deal: the strategy behind Japan’s largest foreign acquisition
03 Sep 2019 //
PHARMACEUTICAL TECHNOLOGY
Health Canada Issues Recall of Shire Pharma Canada ULC Vyvanse Capsule
14 Aug 2019 //
HEALTH CANADA
FDA rejects Kala`s dry eye drug; Troubled Insys finds a buyer in Hikma
10 Aug 2019 //
ENDPTS
Still on a cash-raising spree, Takeda shops €1.5B European drug sale: report
19 Jul 2019 //
FIERCE PHARMA
Tiaki hires Bruhn as CEO for Alzheimer`s drug discovery push
11 Jul 2019 //
FIERCE BIOTECH
Takeda investors want executives to return pay if performance lags
03 Jul 2019 //
FIERCE PHARMA
Takeda sets December deadline for U.S. employees` Boston move
27 Jun 2019 //
FIERCE PHARMA
Aldeyra`s eye drug fails pivotal test for rare, inflammatory disease
25 Jun 2019 //
ENDPTS
Mirum spells out plans to turn Shire discards into orphan liver drug successes
24 Jun 2019 //
ENDPTS
The top 10 most-expensive meds in the U.S.—and they`re not the usual suspects
13 Jun 2019 //
FIERCE PHARMA
Servier, armed with Shire cancer drugs, builds out vision for U.S. future
08 Jun 2019 //
FIERCE PHARMA
BioCryst shares are blasted as a PhIII HAE ‘success’ underwhelms analysts
21 May 2019 //
ENDPTS
Bill Haney’s Skyhawk spears marquee alliance for its work drugging RNA in Takeda
07 May 2019 //
ENDPTS
Takeda appoints Andrey Potapov as ICMEA area head
30 Apr 2019 //
BUSINESS-STANDARD
A Dry Eye treatment aimed at mitochondria
15 Apr 2019 //
FIERCE BIOTECH
AbbVie, Shire investors settle lawsuit over scuttled merger
13 Apr 2019 //
FIERCE PHARMA
Peter Hecht recruits Bayer/Shire vet Andreas Busch for post at his $175M spinout
09 Apr 2019 //
ENDPTS
Shire R&D chief Andy Busch jumps ship amid Takeda megamerger
09 Apr 2019 //
FIERCE BIOTECH
Takeda scouts buyers for Latin American business: report
05 Apr 2019 //
FIERCE PHARMA
FTC zeroes in on potential BMS, Celgene psoriasis overlap
27 Mar 2019 //
ENDPTS
Takeda hits FDA snag on Ninlaro, but its growth still helps drive revenue hike
01 Feb 2019 //
FIERCE PHARMA
Takeda eyes $3B from emerging-market asset cull
22 Jan 2019 //
FIERCE PHARMA
With mega merger season in full swing, Takeda officially swallows Shire
08 Jan 2019 //
ENDPTS
Takeda and rivals chase cancer therapy prize through M&A
07 Jan 2019 //
NIKKEI ASIA
Takeda unlikely to sell OTC drug business - CEO
07 Jan 2019 //
REUTERS
Takeda eyes $31.3 billion in annual sales after Shire acquisition
07 Jan 2019 //
MAINICHI JAPAN
Takeda builds arsenal for immuno-oncology research, creates cell therapy group
03 Jan 2019 //
ENDPTS
Supernus Pharma`s ADHD drug meets main goal in study on adolescents
21 Dec 2018 //
REUTERS
Shire gears up to battle Allergan`s Linzess with new constipation drug Motegrity
17 Dec 2018 //
FIERCE PHARMA
Shire`s Biological Takhzyro (lanadelumab) Receives Approval in Europe
17 Dec 2018 //
EMA
Shinichi Tamura reclaims the helm at Sosei as CEO Peter Bains hits the exit
12 Dec 2018 //
ENDPTS
Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals
10 Dec 2018 //
PATENT LITIGATION
Takeda-Shire finish line; Sun’s crisis; J&J-Legend CAR-T
07 Dec 2018 //
FIERCE PHARMA
Takeda could rack up $10B in selloffs after controversial Shire buyout: report
01 Dec 2018 //
FIERCE PHARMA
